This presentation discusses the Atypical Vascular Lesion (AVL), a term the speaker finds confusing due to the lesion’s generally benign nature. AVL is defined as a benign vascular proliferation arising specifically in sites previously treated with radiation. Clinically, AVL is characterized by small, flesh-colored papules, which is the key differentiator from the more aggressive post-radiation angiosarcoma (AS), which typically presents as purpuric plaques or nodules. Histologically, AVL shows infiltrative growth, resembling a lymphangioma, but lacks the significant pleomorphism and mitotic activity seen in AS. The gold standard for differentiating AVL from AS when histology is ambiguous is the use of CMYC amplification testing (FISH); AVL is negative, while post-radiation AS is typically positive. Though most AVLs are considered benign and non-precursor lesions, conservative excision is often recommended to rule out an underlying, unsampled angiosarcoma, followed by close patient follow-up.
Summarizing Atypical Vascular Lesion (AVL)
0:02 Terminology Critique: The speaker expresses dissatisfaction with the name "Atypical Vascular Lesion" (AVL) because the proliferation is typically benign (not truly atypical) and the name is too descriptive, leading to confusion.
0:17 Definition and Etiology: AVL is a benign vascular proliferation that develops exclusively in skin sites previously exposed to radiation.
0:25 Histological Appearance: Histologically, AVL often mimics a lymphangioma or lymphatic malformation, displaying infiltrative growth but initially lacking pronounced atypia.
0:32 Crucial Clinical Distinction (Key Takeaway): Clinically, AVL presents as small, flesh-colored papules within the radiation field. This presentation is essential for distinguishing it from angiosarcoma (AS), which typically presents as purpura, large nodules, or plaques.
0:55 Microscopic Features: AVL channels infiltrate between collagen bundles. Endothelial cells may show mild hyperchromasia but generally lack the severe features of AS, such as multi-layering, mitoses, and pleomorphism.
1:32 Management Recommendation: If the diagnosis is unclear due to infiltrative growth, conservative excision of the AVL is recommended to ensure that an underlying angiosarcoma is not missed.
1:43 Prognosis and Progression: Most experts believe the majority of AVLs are benign and do not progress to angiosarcoma; they likely arise in the radiation setting similarly to AS, but are not necessarily precursor lesions.
1:51 Molecular Differentiation (Key Diagnostic Tool): To definitively distinguish AVL from post-radiation AS, CMYC amplification testing (FISH) is recommended. AVL is negative for CMYC amplification, while post-radiation AS is usually positive.
2:40 Follow-up: Close follow-up is recommended for AVL patients to monitor for any new vascular lesions.
2:50 Handling Multiple Lesions: In rare cases where patients develop multiple AVLs (e.g., 30–50 lesions), complete excision is not feasible, and only close clinical follow-up is possible.